Genotypic Correlation of a Virologic Response to Lamivudine, Stavudine and Nevirapine in Patients for Whom Combination Therapy Had Failed

Authors

Mirza Khalil Bahmani1, Ayyoob Khosravi1,*, Fereidoun Mahboodi2, Ramin SarramiForooshani2
1HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran
2Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IR Iran
*Corresponding Author: HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran, [email protected]. Email: [email protected]

Archives of Clinical Infectious Diseases:Vol. 3, issue 4; 215-9
Published online:Oct 31, 2008
Article type:Brief Report
How to Cite:Bahmani MK, Khosravi A, Mahboodi F, SarramiForooshani R. Genotypic Correlation of a Virologic Response to Lamivudine, Stavudine and Nevirapine in Patients for Whom Combination Therapy Had Failed. Arch Clin Infect Dis. 2008;3(4):. doi:

Abstract

Background:

Resistance is the consequence of mutations that emerge in the viral proteins targeted by antiretroviral agents. Thus, we focused our attention on mutations in HIV-1 reverse transcriptase to define their association with specific NRTIs and NRTI resistance mutations at therapeutic failure.

Patients and methods:

The study population included 5 Iranian HIV-positive patients referring to Counseling Behavioral Modification Center in Shiraz who received a combination of antiretroviral therapy (lamivudine, stavudine and nevirapine). PBMC DNA was isolated from blood and PCR was performed to produce a 1200 bp amplicon and resolved by electrophoresis on a 0.7% agarose TBE gel, visualized with ethidium bromide. PCR products from HIV-1- infected patients were cloned into pCR2.1TOPO, then sequenced. Finally, sequence data were analyzed.

Results:

Results showed drug resistance in 2 patients, of whom one had NNRTI resistance mutations (M230G, L234R and K238H) and other had both NRTI (V75M) and NNRTI (F227L) resistance mutations.

Conclusion:

Confirmation of genetic resistance in HIV-positive patients who show therapy failure can help physicians to change their drug regime in order to achieve better outcome.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

28
Dec
2019
Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

Seyed Ahmad Seyed Alinaghi,
Mehrnaz Rasoolinejad,
Zeinab Najafi,
Omid Dadras,
Ehsan Malekianzadeh,
Ali Mirzazadeh

Seyed Alinaghi SA, Rasoolinejad M, Najafi Z, Dadras O, Malekianzadeh E, et al. Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran. Arch Clin Infect Dis. 2019;14(6):e96531. doi: https://doi.org/10.5812/archcid.96531

26
Sep
2018
A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients

A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients

Zeynab Nasiri-Tajabadi,
Farah Bokharaei Salim,
Mohammad-Javad Najafzadeh,
Saeed Kalantari,
Saba Garshasbi,
Saeid Amel Jamehdar
,et al.

Nasiri-Tajabadi Z, Bokharaei Salim F, Najafzadeh M, Kalantari S, Garshasbi S, et al. A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients. Arch Clin Infect Dis. 2018;13(6):e69153. doi: https://doi.org/10.5812/archcid.69153

31
May
2026
Exploring Virological Failure in HIV/AIDS Treatment: A Cross-sectional Study of Antiretroviral Regimen Efficacy and Predictors in Khorramabad City During 2011 - 2021

Exploring Virological Failure in HIV/AIDS Treatment: A Cross-sectional Study of Antiretroviral Regimen Efficacy and Predictors in Khorramabad City During 2011 - 2021

Kiana Shahzamani,
Somaieh Sabzali,
Saman Moetamedi,
Mehdi Birjandi,
Tabassom Zavari

Shahzamani K, Sabzali S, Moetamedi S, Birjandi M, Zavari T. Exploring Virological Failure in HIV/AIDS Treatment: A Cross-sectional Study of Antiretroviral Regimen Efficacy and Predictors in Khorramabad City During 2011 - 2021. Jundishapur J Microbiol. 2026;19(5):e167579. doi: https://doi.org/10.5812/jjm-167579

15
May
2024
Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran

Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran

Gholam Reza Talei,
Zahra Heydarifard,
Sayyad Khanizadeh

Talei GR, Heydarifard Z, Khanizadeh S. Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran. Jundishapur J Microbiol. 2024;17(3):e145562. doi: https://doi.org/10.5812/jjm-145562

21
Oct
2019
Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017)

Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017)

Mehrnaz Rasoolinejad,
Mohammad Sarraf,
Zeinab Najafi,
SeyedAhmad SeyedAlinaghi,
Banafsheh Moradmand Badie,
Mohammadreza Salehi
,et al.

Rasoolinejad M, Sarraf M, Najafi Z, SeyedAlinaghi S, Moradmand Badie B, et al. Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017). Arch Pediatr Infect Dis. 2019;7(4):e80318. doi: https://doi.org/10.5812/pedinfect.80318

More by these authors

Mirza Khalil BahmaniPubMedScholar
Ayyoob KhosraviPubMedScholar
Fereidoun MahboodiPubMedScholar
Ramin SarramiForooshaniPubMedScholar
Share
Cited by
Metrics